Oct 10, 2018 | Press Releases
Cambridge, MA, October 10, 2018 — Allergan, a leading global pharmaceutical company, has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort...
Sep 25, 2018 | Press Releases
Global Network of Researchers Arrive in Boston to Collaborate and Discuss R&D at TriNetX Summit Cambridge, MA, September 25, 2018 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the creation of...
Jul 31, 2018 | Press Releases
Cambridge, MA, July 31, 2018 — Hadassah Medical Center, a leading healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX global health research network to increase clinical trial activity and help...
Jul 25, 2018 | Press Releases
Cambridge, MA, July 25, 2018 — Carilion Clinic, a not-for-profit healthcare organization serving nearly one million residents in western Virginia, has joined the TriNetX global health research network to better assess its patient population for the feasibility of...
Jun 12, 2018 | Press Releases
Cambridge, MA, June 12, 2018 — The Cardiovascular Research Consortium (CRC), a nationwide network of community-based cardiology practices, has selected TriNetX’s real-world evidence platform to provide the biopharmaceutical industry with the first-of-its-kind access...
Jun 4, 2018 | Press Releases
Tallinn, ESTONIA, 4 June, 2018 — Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally. TriNetX’s rapidly...
May 21, 2018 | Press Releases
Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness BALTIMORE, MD – ISPOR 2018 – May 21, 2018 – TriNetX™, the global health research network, today announced the availability of TriNetX...
May 19, 2018 | Events, Published Research
Presented at ISPOR 2018, this poster investigates using real world data to establish an optimal treatment target for Hba1c in diabetes type 2. Stapff MP, Palm S, Stacey J TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...
May 19, 2018 | Events, Published Research
Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients. Stacey J, Hilderbrand S, Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...
May 19, 2018 | Events, Published Research
Presented at ISPOR 2018, this poster is a comparison of bleeding events, strokes, and myocardial infarcts on warfarin or dabigatran for treatment of atrial fibrillation: results of a real-world data analysis. Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018...
